Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Roche claims new 5-HT6 receptor ligands for cognitive disorders, psychosis, etc.

Oct. 27, 2004

Novel JNK inhibitors and their use reported by Eisai

Oct. 27, 2004

Zonisamide reported effective and safe in children with epilepsy

Oct. 26, 2004

Synthesis of highly potent peptidomimetic beta-secretase inhibitors

Oct. 26, 2004

Preclinical evidence for the antiapoptotic effects of tempol in the brain

Oct. 26, 2004

Tiagabine shows promise in anxiety and PTSD

Oct. 26, 2004

Aricept ODT receives FDA approval

Oct. 26, 2004

New adenine derivative shows antidepressant-like effects in vivo

Oct. 25, 2004

Novel antidepressant may improve side effect profile of selective serotonin reuptake inhibitors

Oct. 25, 2004

Rotigotine prevents neuronal degeneration in a mouse model of PD

Oct. 25, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...